EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
https://doi.org/10.15829/1560-4071-2014-12-71-75
Abstract
Aim. Evaluation of clinical efficacy and tolerability of beta-blockers in premenopausal women with stable angina.
Material and methods. The anaysis of 43-55 years old premenopausal 50 women with stable angina was performed. Therapy included enalapril 2,5-10 mg daily, betaadrenoblocker in 1 group (23 persons) – 5-10 mg of bisoprolol daily, and in 2 group (27 pers.) nebivolol 2,5-5 mg daily (Nebilet®, “Berlin-Chemie/A. Menarini”, Germany), acetylsalycilic acid 100 mg daily during 6 months. The studies done were veloergometry, long-lasting ECG monitoring, echocardiography and also the test with reactive hyperemia on brachial artery. Severity of anxiety-depressive syndrome was evaluated usin hospital scale of anxiety and depression, and the severity of climacteric disorders – by the M. Kuppermann index.
Results. With the therapy all patients self-reported improvement of their condition: in 80% there was a decrease of angina functional class, more significant in the second group. Also there was decrease of climacteric symptoms salience as anxiety-depressive disorders, especially in nebivolol group. By the results of ECG monitoring, i. e. frequency of rhythm dosirders (supraventricular and ventricular arrhythmias) there was lower quantity of episodes, more significant in nebivolol group. All groups showed an increase of basal brachial artery diameter, more significant in the 2nd group. Also we marked the changes in central hemodynamics parameters and sctructure-functional parameters of the left ventricle in both groups.
Conclusion. Nebilet® in saily dose as 2,5-5 mg is an effective antianginal drug in women with CHD and stable angina pectoris. Under Nebilet® action there is improvement of systolic and diastolic functions of the left ventricle myocardium. With Nebilet® women with stable angina significantly increase exercise tolerance and there is a decrease of climacteric and anxiety-depressive syndrome.
About the Authors
N. A. Koryagina
Perm’ State Medical Academy named after E. A. Wagner;
Women Health Clinic, Perm’
Russian Federation
Russian Federation
A. V. Petrishcheva
Perm’ State Medical Academy named after E. A. Wagner
Russian Federation
Russian Federation
References
1. Popov AA, Izmozherova NV, Tagil’ceva NV, et al. Comparative evaluation criteria of the metabolic syndrome in women in the menopausal period. Problems of endocrinology 2008, 3: 11-4. (Попов А. А., Изможерова, Н. В. Тагильцева Е. В. и др.) Сравнительная оценка критериев метаболического синдрома у женщин в климактерическом периоде. Проблемы эндокринологии 2008, 3: 11-4).
2. Lobo RA. Treatment of the postmenopausal women/ basic and clinical aspects (III ed., 2007. — 1200p).
3. Cho GJ, Park HT, Shin JH, et al. The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women. Menopause 2009; 16: 5: 998-1003.
4. Mosca L Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109: 672-93.
5. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologist and gynaecologist. Eur Heart J 2007; 28: 2024-8.
6. Polikarpov LS, Hamnagadaev II, Jaskevich RA, et al. The role of risk factors in the development of coronary heart disease in different ecological conditions of Siberia. The materials of the Russian national Congress of cardiologists. Abstracts of Saint-Petersburg, 2002: 325-6. (Поликарпов Л. С., Хамнагадаев И. И., Яскевич Р. А. и др) Роль факторов риска в развитии ишемической болезни сердца в различных экологических условиях Сибири. Материалы Российского национального конгресса кардиологов. Тезисы доклада Санкт-Петербург, 2002: 325-6).
7. Glejzer MG. Arterial hypertension and diabetes mellitus. Comsilium medicum 2004; 5: 333-41. (Глезер М. Г. Артериальная гипертония и сахарный диабет. Comsilium medicum. 2004; 5: 333-41).
8. Glejzer MG, Bojko NV, Abil’dinova AZh, et al. Risk factors of Moscow population of patients with hypertension. Russ J Cardiol 2002; 6: 1-5. (Глейзер М. Г., Бойко Н. В., Абильдинова А. Ж., и др. Факторы риска у московской популяции больных с АГ. Российский кардиологический журнал 2002; 6: 1-5).
9. Shal’nova SA, Deev AD, Oganov RG. Factors affecting the mortality from cardiovascular diseases in the Russian population. Cardiovascular Therapy and Prevention 2005; 1: 4-9. (Шальнова С. А., Деев А. Д., Оганов Р. Г. Факторы, влияющие на смертность от сердечно-сосудистых заболеваний в российской популяции. Кардиоваскулярная терапия и профилактика 2005; 1: 4-9).
10. Kucherov MG, Kodochigova AI, Martynova AG, et al. Abdominal distribution of fat tissue in women as a risk factor for cardiovascular disease. Health and education in the XXI century: proceedings of the fifth scientific-practical conference with international participation Moscow, 2004:66. (М. Г. Кучеров, А. И. Кодочигова, А. Г. Мартынова и др. Абдоминальный тип распределения жировой ткани у женщин как фактор риска развития сердечно-сосудистых заболеваний. Здоровье и образование в XXI веке: Материалы V научно-практической конференции с международным участием Москва, 2004:66).
11. Mackeplishvili ST, Gukasjan LV, Kamardinov DH, et al. Endothelial dysfunction as a key element in the development of atherosclerosis. Therapeutic strategies in endothelial dysfunction (review). In the book: Bulletin Bakulev them. A. N. Bakulev RAMS. Cardiovascular disease 9, 2004; 5: 76-83. (Мацкеплишвили СТ., Гукасян Л. В., Камардинов Д.Х и др. Эндотелиальная дисфункция как ключевое звено развития атеросклероза. Терапевтические стратегии при эндотелиальной дисфункции (обзор). В сборнике: Бюллетень НЦССХ им. А. Н. Бакулева РАМН. Сердечнососудистые заболевания. 9, 2004; 5: 76-83).
12. Korjagina NA, Vasilec LM, Grigoriadi NE, et al. The experience of identifying episodes of painless myocardial ischemia in women with arterial hypertension in the conditions of private medicine. Protivorechija sovremennoj kardiologii: spornye i nereshennye voprosy: materialy mezhdunar. nauch.-prakt. Konf, 2013:82. (Корягина Н. А., Василец Л. М., Григориади Н. Е. и др) Опыт выявления эпизодов безболевой ишемии миокарда у женщин с артериальной гипертензией в условиях частной медицины. Противоречия современной кардиологии: спорные и нерешенные вопросы: материалы Mеждународной научно-практической конференции, 2013: 82).
13. Koryagina NA, Petrischeva A, Vasilets L, et al. Heart rate variability and levels of cytokines depending on the detection of cardiovascular disease in the working population of Russia (eng). Eur J internal medicine, 2013;8 -.
14. Mosca L, Collins P, Herrington DM, et al. Circulation 2001; 104:499–503.
15. Herrington DM. Eur Heart J 2001; 3 (SupplM): M7–M11.
16. Silmon T, Jaillon P. Eur HeartJ 2000; 2 (SupplG): G2–G6.
17. Dobordzhginidze LM, Nechaev AS, Gracianskij NA. Metabolic risk factors in women with premature coronary heart disease. Cardiology, 1999; 9: 31-40. (Доборджгинидзе Л. М., Нечаев А. С., Грацианский Н. А. Метаболические факторы риска у женщин с преждевременной ишемической болезнью сердца. Кардиология, 1999; 9: 31-40).
18. Shalygina LS. Normative-legal regulation of working with information systems and personal data. — M.: “Medical law”, 2010; 2: 35-39. (Шалыгина Л. С. Нормативноправовое регулирование работы с информационными системами и персональными данными. — М.: “Медицинское право”. 2010; 2: 35-39).
Review
For citations:
Koryagina N.A., Petrishcheva A.V. EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE. Russian Journal of Cardiology. 2014;(12):71-75. (In Russ.) https://doi.org/10.15829/1560-4071-2014-12-71-75
Views:
5302
Email this article 